129 related articles for article (PubMed ID: 22054202)
1. Endogenous plasma erythropoietin, cardiovascular mortality and all-cause mortality in renal transplant recipients.
Sinkeler SJ; Zelle DM; Homan van der Heide JJ; Gans RO; Navis G; Bakker SJ
Am J Transplant; 2012 Feb; 12(2):485-91. PubMed ID: 22054202
[TBL] [Abstract][Full Text] [Related]
2. High plasma guanidinoacetate-to-homoarginine ratio is associated with high all-cause and cardiovascular mortality rate in adult renal transplant recipients.
Hanff E; Said MY; Kayacelebi AA; Post A; Minovic I; van den Berg E; de Borst MH; van Goor H; Bakker SJL; Tsikas D
Amino Acids; 2019 Nov; 51(10-12):1485-1499. PubMed ID: 31535220
[TBL] [Abstract][Full Text] [Related]
3. Plasma ADMA, urinary ADMA excretion, and late mortality in renal transplant recipients.
Said MY; Bollenbach A; Minović I; van Londen M; Frenay AR; de Borst MH; van den Berg E; Kayacelebi AA; Tsikas D; van Goor H; Navis G; Bakker SJL
Amino Acids; 2019 Jun; 51(6):913-927. PubMed ID: 30915571
[TBL] [Abstract][Full Text] [Related]
4. Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus Study.
den Elzen WP; Willems JM; Westendorp RG; de Craen AJ; Blauw GJ; Ferrucci L; Assendelft WJ; Gussekloo J
CMAJ; 2010 Dec; 182(18):1953-8. PubMed ID: 21149533
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.
Kaisar MO; Armstrong K; Hawley C; Campbell S; Mudge D; Johnson DW; Prins JB; Isbel NM
BMC Nephrol; 2009 Oct; 10():29. PubMed ID: 19821969
[TBL] [Abstract][Full Text] [Related]
6. High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND.
Grote Beverborg N; van der Wal HH; Klip IT; Voors AA; de Boer RA; van Gilst WH; van Veldhuisen DJ; Gansevoort RT; Hillege HL; van der Harst P; Bakker SJ; van der Meer P
Eur J Heart Fail; 2016 Jul; 18(7):814-21. PubMed ID: 26781914
[TBL] [Abstract][Full Text] [Related]
7. Association of hepcidin-25 with survival after kidney transplantation.
Eisenga MF; Dullaart RP; Berger SP; Sloan JH; de Vries AP; Bakker SJ; Gaillard CA
Eur J Clin Invest; 2016 Dec; 46(12):994-1001. PubMed ID: 27696386
[TBL] [Abstract][Full Text] [Related]
8. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
[TBL] [Abstract][Full Text] [Related]
9. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters.
Florit EA; Hadad F; Rodriguez Cubillo B; De la Flor JC; Valga F; Perez Flores I; Calvo Romero N; Valero San Cecilio R; Barrientos Guzman A; Sanchez Fructuoso A
Transplant Proc; 2012 Nov; 44(9):2590-2. PubMed ID: 23146464
[TBL] [Abstract][Full Text] [Related]
10. Serum free sulfhydryl status is associated with patient and graft survival in renal transplant recipients.
Frenay AS; de Borst MH; Bachtler M; Tschopp N; Keyzer CA; van den Berg E; Bakker SJL; Feelisch M; Pasch A; van Goor H
Free Radic Biol Med; 2016 Oct; 99():345-351. PubMed ID: 27554970
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients.
Massy ZA; Chadefaux-Vekemans B; Chevalier A; Bader CA; Drüeke TB; Legendre C; Lacour B; Kamoun P; Kreis H
Nephrol Dial Transplant; 1994; 9(8):1103-8. PubMed ID: 7800208
[TBL] [Abstract][Full Text] [Related]
12. Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all-cause mortality in renal transplant recipients.
Osté MCJ; Gomes-Neto AW; Corpeleijn E; Gans ROB; de Borst MH; van den Berg E; Soedamah-Muthu SS; Kromhout D; Navis GJ; Bakker SJL
Am J Transplant; 2018 Oct; 18(10):2523-2533. PubMed ID: 29464830
[TBL] [Abstract][Full Text] [Related]
13. Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study.
Yepes-Calderón M; Sotomayor CG; Gans ROB; Berger SP; Leuvenink HGD; Tsikas D; Rodrigo R; Navis GJ; Bakker SJL
Nephrol Dial Transplant; 2020 Mar; 35(3):512-519. PubMed ID: 32133530
[TBL] [Abstract][Full Text] [Related]
14. Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores.
Mansell H; Rosaasen N; Dean J; Shoker A
Clin Transplant; 2013; 27(4):E391-9. PubMed ID: 23782452
[TBL] [Abstract][Full Text] [Related]
15. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
Soveri I; Holdaas H; Jardine A; Gimpelewicz C; Staffler B; Fellström B
Nephrol Dial Transplant; 2006 Aug; 21(8):2282-9. PubMed ID: 16574686
[TBL] [Abstract][Full Text] [Related]
16. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
[TBL] [Abstract][Full Text] [Related]
17. Statin use and incident cardiovascular events in renal transplant recipients.
Anderson JLC; van der Giet M; Gomes Neto AW; Bakker SJL; Tietge UJF
Eur J Clin Invest; 2021 Nov; 51(11):e13594. PubMed ID: 34042174
[TBL] [Abstract][Full Text] [Related]
18. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
Wagner M; Alam A; Zimmermann J; Rauh K; Koljaja-Batzner A; Raff U; Wanner C; Schramm L
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1573-9. PubMed ID: 21734083
[TBL] [Abstract][Full Text] [Related]
19. [Related factors of endogenous erythropoietin and its association with 10-year risks of cardiovascular disease in a community-based Chinese study].
Chen CY; Sun PF; Zhao J; Jia J; Fan FF; Wang CY; Li JP; Jiang YM; Huo Y; Zhang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1068-1073. PubMed ID: 38101791
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population.
Oterdoom LH; de Vries AP; van Ree RM; Gansevoort RT; van Son WJ; van der Heide JJ; Navis G; de Jong PE; Gans RO; Bakker SJ
Transplantation; 2009 May; 87(10):1562-70. PubMed ID: 19461495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
